BioRestorative Therapies, Inc. Logo

BioRestorative Therapies, Inc.

A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.

BRTX | NDAQ

Overview

Corporate Details

ISIN(s):
US0906556065
LEI:
Country:
United States of America
Address:
40 MARCUS DRIVE, 11747 MELVILLE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioRestorative Therapies, Inc. is a clinical-stage regenerative medicine company focused on developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. The company's lead clinical program centers on BRTX-100, an investigational single-dose therapy derived from bone marrow mesenchymal stem cells, which is in a Phase 2 trial for treating chronic lumbar disc disease. In addition to addressing chronic pain, BioRestorative is developing a pipeline of brown adipose-derived stem cell therapies for metabolic disorders. The company also has a commercial-facing BioCosmeceutical platform that leverages its secretome and exosome-based biologics for applications in aesthetic medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden BIOG
Bio-Gate AG Logo
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
Germany BIG1
BIOGEN INC. Logo
Develops innovative therapies for complex neurological and neurodegenerative conditions.
United States of America BIIB
Bio Green Med Solution, Inc. Logo
Develops cancer medicines and supplies fire safety equipment for global markets.
United States of America BGMS
BIOHARVEST SCIENCES INC. Logo
Biotech platform that grows plant cells to produce active compounds for human wellness products.
United States of America BHST
Biohaven Ltd. Logo
Clinical-stage biopharma developing drugs for neuroscience, immunology, and oncology.
United States of America BHVN
BioInfra Co.,Ltd. Logo
Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.
South Korea 199730
BioInfra Life Science Inc. Logo
Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.
South Korea 266470
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden BINV
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel BLRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.